Current approaches to the external therapy of photodermatoses

Abstract

Remedial measures for photodamages of skin are mainly aimed at elimination of inflammation and subjective sensations
such as burning and itching. Topical corticosteroids remain leading drugs in the external therapy of phototrauma,
phototoxic and photoallergic reactions. Mometasone furoate (Elocom) has high anti-inflammatory and antiallergic
activity. Moreover, the composition of the Elocom cream is based on titanium dioxide, a classical mineral screen,
which makes it possible to use the Elocom cream in case of steroid-sensitive pathology under conditions of high solar
exposure. The Elocom cream has been used in the monotherapy and complex treatment of solar dermatitis, actinic
cheilitis, polymorphous light eruption, discoid lupus erythematosus and actinic prurigo. Regression of manifestations of
solar dermatitis was recorded on Day 1-3 of treatment, and regression of manifestations of actinic cheilitis - during
Week 2 of treatment. The process in case of photoallergic reactions and discoid lupus erythematosus was over during
Week 3-4 of treatment. Substances making a part of the composition of the Elocom cream and having photoprotective
properties make this cream a drug of choice for its use on skin areas subject to solar exposure in case of steroidsensitive
pathology including phototrauma, phototoxic and photoallergic reactions. Besides, photoprotective properties
of the Elocom cream explain why it should be selected for treatment of steroid-sensitive dermatoses becoming more
severe or appearing after solar exposure, in case of localization of eruptions on open skin areas (face, neck, decollete
area, hands, etc.)

References

  1. Epstein J.H. Photocarcinogenesis, skin cancer, and aging. J Am Acad Dermatol 1993; 9: 487-492.
  2. El-Domyati M., Attia S., Murano F. et al. Intrinsic aging vs photoaginga: a comparative histopathological, immunohistochemical, and ultrastructural study of skin. Exp Dermatol 2002, 11: 398-405.
  3. Дерматоонкология. Под. ред. Г.А. ГалилОглы, В.А. Молочкова, Ю.В. Сергеева. Медицина для всех. М., 2005.
  4. Акимов В.Г. Биологические эффекты ультрафиолетового облучения кожи. Вестн. дерматол. и венерол. 2008; 3: 81-84.
  5. В.Г. Акимов. Фотозависимые дерматозы. Медицинское информационное агентство. М., 2010.
  6. Stratigos A.J., Antoniou C., Papathanakou E. Spectrum of idiopathic photodermatoses in Mediterranean country. Int J Dermatol 2003, 42: 449-454.
  7. Dawe R.S., Crombie I.K., Ferguson J. The natural history of chronic actinic dermatitis. Arch Dermatol 2000, 136: 1215-1220.
  8. Hussain K. Summertime actinic lichenoid eruption, a distinct entity, should be termed actinic lichen nitidus. Arch Dermatol 1998; 134: 1302-1303.
  9. Bolognia J.L., Jorizzo J.L., Rapini R.P. Dermatology. 2nd. ed., NY 2008.
  10. Солнцезащитные экраны. Европейское руководство по лечению дерматологических бо- лезней. Под ред. А.Д. Кацамбаса, Т.М. Лотти. Медпресс-информ М., 2008.
  11. Gramvusskakis S., George S.A. Chronic actinic dermatitis (photosensitivity dermatitis/ actinic reticuloid syndrome) beneficial effect from hydroxyurea. Br J Dermatol 2000, 143: 1340-1344.
  12. Monfrecola G., Masturzo E., Riccardo A.M. Solar urticaria: a report on 57 cases. Am J Contct Dermat 2000, 11; 89-94.
  13. Barnes P.J. Molecular mechanisms of corticosteroids in allergic deseases. Allergy 2001; 56: 928-936.
  14. Scherer R., Nowok K. Erste erfahrungen mit mometason furoat in derpraxiszein neues topisches kortikoid mit verbessertem risikoznutzen verhaltnis. Detch Derm 1995; 43: 280-288.
  15. Schoepe S., Billich A. Glucocorticoid-indused skin atrophy. Exp Dermatol 2006; 15: 406-420.

Statistics

Views

Abstract: 706

PDF (Russian): 550

Article Metrics

Metrics Loading ...

Dimensions

PlumX

Refbacks

  • There are currently no refbacks.

Copyright (c) 2011 Khlebnikova A.N., Khlebnikova A.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies